Abstract 3224: Cucurbitacin D inhibits prostate tumor growth via targeting glucose metabolism

Volume: 77, Pages: 3224 - 3224
Published: Jul 1, 2017
Abstract
Background: Emergence of hormone-refractory PrCa (HRPC) after the anti-androgen therapy, cancer metastasis and chemo-resistance are the major hurdle for the treatment of prostate cancer (PrCa) patients. Accumulative evidence suggests that altered glucose metabolism is one of the mechanisms for metastatic PrCa cell survival and chemo-resistance. Therefore, identification and generation of natural/or synthetic pharmacological agents that can limit...
Paper Details
Title
Abstract 3224: Cucurbitacin D inhibits prostate tumor growth via targeting glucose metabolism
Published Date
Jul 1, 2017
Volume
77
Pages
3224 - 3224
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.